Thermo Fisher Scientific, Telangana Govt to establish Bioprocess Design Centre in Hyderabad
Thermo FisherScientific has announced the signing of a
Memorandum of Understanding (MoU) with the Government of Telangana to establish
a Bioprocess Design Centre (BDC) in Genome Valley, Hyderabad.
by Shri Duddilla Sridhar Babu, Minister for Information Technology, Department
of Electronics & Communications (ITE&C), Department of Industries
& Commerce (I&C) and Legislative Affairs, Shri. Jayesh Ranjan IAS, Special Chief Secretary, Department
of I&C and Shri Shakthi Nagappan, CEO, Telangana Lifesciences, Govt. of
Telangana.
Joining them was the
senior leadership team from Thermo Fisher Scientific, including Fred Lowery,
Executive Vice President & President, Lab Products and BioProduction, Daniella
Cramp, Sr. Vice President & President, BioProduction, Tony Acciarito,
President, APJ, Srinath Venkatesh, Managing Director, India & South Asia and
Sarita Rawat, Sr. Director, Bio Production & Corporate Accounts.
“Totalling
10,000 sq. ft., the Bioprocess Design Centre will become operational in early
2025 and serve as a benchmark to accelerate the development and manufacturing
of innovative biotherapeutics in India and Asia-Pacific region,” the Company stated. The Centre will
feature state-of-the-art labs as well as training hubs to drive scientific research.
Shri
Duddilla Sridhar Babu,
Minister for ITE&C and I&C Departments, commented, “Telangana has
consistently demonstrated its commitment to fostering innovation and nurturing
world-class ecosystems for biotech and life sciences industries. The
establishment of this Bioprocess Design Centre reflects the state’s progressive
policies and collaborative approach to building a robust biopharma
infrastructure. With over 1,800 companies, Telangana is leading the way in
making India a global hub for biopharma innovation. We are thrilled to partner
with Thermo Fisher, the world leader in serving science, in this transformative
initiative that will advance the future of healthcare.”
Shakthi
Nagappan,
Director of Lifesciences and Pharma, Government of Telangana, stated, “This
partnership with Thermo Fisher marks a significant milestone in our efforts to
build a first-of-its-kind bioprocessing facility for biologics manufacturing in
India. The centre, featuring single-use bioreactors, will enhance the biopharma
sector by offering pay-per-use infrastructure, technical expertise, and
cutting-edge research solutions, helping companies reduce their time to market.
It will not only drive the growth of biopharma manufacturing in Telangana but
also bolster India’s position on the global map.”
Thermo
Fisher will equip the centre with advanced workflow capabilities across
upstream and downstream research, cell culture media development, single-use
scale-up manufacturing, and product validation.
Speaking
on the occasion, Daniella Cramp, Sr. Vice President & President, BioProduction,
Thermo Fisher Scientific said, “I sincerely thank
the Government of Telangana for partnering with Thermo Fisher and supporting
our Mission. This state-of-the-art
facility will enable academic researchers, biopharma start-ups and companies to
fast-track their innovations by meeting their end-to-research and manufacturing
needs.”
Acciarito, President, APJ, Thermo Fisher Scientific, further
added, “The signing of this MoU marks an exciting new
chapter for Thermo Fisher in India, reaffirming our continued commitment to fostering
scientific innovation in the country. Our partnership with the Government of
Telangana will strengthen India’s biopharma manufacturing capabilities,
accelerating the development of breakthrough therapeutics and advancing
healthcare solutions that will benefit patients globally.”
Srinath
Venkatesh,
Managing Director, India & South Asia, Thermo Fisher Scientific, said,
“India is fast emerging as a global biopharma hub, with significant growth in
research and development driven by key pharmaceutical and biotech companies.
The Bioprocess Design Centre underscores our commitment to empowering our
customers through technological advancements. By focusing on areas like
oncology, cell and gene therapies, and biotherapeutics, we aim to drive
breakthroughs for a healthier world.”
Hyderabad
is recognized as the new destination for large biotech and life sciences
companies due to enabling government policies and industrial practices, infrastructure
facilities and a diverse talent ecosystem of skilled professionals in
chemistry, biology, genetics, technology and beyond.
Thermo
Fisher has a state-of-the-art R&D and engineering
centre in Hyderabad for supporting product designing, development, reliability
performance testing and verification, as well as validation of products.
Earlier
this year, Thermo Fisher also partnered with leading bio-incubators to set up
five Centres for Innovation at Centre for Cellular
and Molecular Platforms (C-CAMP), Bengaluru, Atal Incubation Centre – Centre
for Cellular Molecular Biology (AIC-CMB), Hyderabad, Aspire Bionest, Hyderabad,
IIT Bionest, Guwahati and KIIT-TBI, Bhubaneshwar. These centres are providing
start-ups access to Thermo Fisher’s advanced technologies and expertise,
significantly reducing the time to market for new biopharma products.
government of India has launched many schemes to accelerate biopharma research
and development, including BioE3 and Bio-RIDE, among others. Telangana
continues to lead this from the forefront and has already readied this
facility. With initiatives like the Bioprocess Design Centre, Thermo Fisher and
Telangana Government are confident of propelling India’s biopharma ecosystem to
new heights.
Read also: Bayer, Thermo Fisher Scientific join hands to increase patient access to precision cancer medicines
